Literature DB >> 2834360

On the membrane topology of vertebrate cytochrome P-450 proteins.

D R Nelson1, H W Strobel.   

Abstract

Hydropathy profiles of 34 aligned cytochrome P-450 sequences were compared to identify potential transmembrane segments. Eleven regions with the potential to cross a membrane in at least some P-450 sequences were detected. The known sidedness of several residues and peptides was used to eliminate some of these regions from consideration. Further arguments based on the location and orientation of the heme relative to the membrane excluded others. This process of elimination was continued until only two regions remained. These two segments, present in the first 66 amino acids of the P-450 NH2 termini, are proposed as the only transmembrane peptides of vertebrate microsomal P-450s. Mitochondrial P-450s may have a different membrane association. The three-dimensional structure of cytochrome P-450cam was examined for the location of conserved charged residues. These residues occurred mainly on the opposite surface from the substrate-binding site and along the edges of the flat triangular P-450cam. A model is proposed for vertebrate microsomal P-450s that is similar to P-450cam. The substrate-binding site faces the membrane, the heme is parallel to the membrane surface, and two NH2-terminal transmembrane segments anchor the protein to the bilayer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834360

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.

Authors:  F De Rienzo; F Fanelli; M C Menziani; P G De Benedetti
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

Review 2.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  The sequence homologies of cytochromes P-450 and active-site geometries.

Authors:  D F Lewis; H Moereels
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

4.  Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego.

Authors:  Michael Fairhead; Silva Giannini; Elizabeth M J Gillam; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2005-11-09       Impact factor: 3.358

5.  Functions of signal and signal-anchor sequences are determined by the balance between the hydrophobic segment and the N-terminal charge.

Authors:  M Sakaguchi; R Tomiyoshi; T Kuroiwa; K Mihara; T Omura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Purification and properties of a shortened form of cytochrome P-450 2E1: deletion of the NH2-terminal membrane-insertion signal peptide does not alter the catalytic activities.

Authors:  J R Larson; M J Coon; T D Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 7.  Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.

Authors:  Li-Qiang Zhao; Su Han; Hao-Ming Tian
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

8.  Passenger protein determines translocation versus retention in the endoplasmic reticulum for aromatase expression.

Authors:  Jasmeet Kaur; Himangshu S Bose
Journal:  Mol Pharmacol       Date:  2013-11-26       Impact factor: 4.436

9.  Cytochrome P450 superfamily in Arabidopsis thaliana: isolation of cDNAs, differential expression, and RFLP mapping of multiple cytochromes P450.

Authors:  M Mizutani; E Ward; D Ohta
Journal:  Plant Mol Biol       Date:  1998-05       Impact factor: 4.076

10.  Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.

Authors:  A D Vaz; S J Pernecky; G M Raner; M J Coon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.